Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for HTLV III gp120 (compound)
Most Correlated Studies
- B cells activated with anti-IgM and CpG DNA then treated with high affinity HIV gp120 protein R66M
- Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
- Neuronal damage by HIV glycoprotein 120 expression in CCR5 KO and wildtype mice
- Dorsal root ganglia from rats modeling neuropathic pain by treatment with gp120 with ddC
- PBMCs of donors immunized with RV144 (ALVAC-gp120) HIV vaccine showing high or low ADCP
Most Relevant Literature
- In silico and in vivo studies of gp120-HIV-derived peptides in complex with G4-PAMAM dendrimers.
- MicroPET evidence for a hypersensitive neuroinflammatory profile of gp120 mouse model of HIV.
- Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epit…
- Unraveling the structural basis of HIV-1 neutralization.
- Nonrandom distribution of cryptic repeating triplets of purines and pyrimidines (RNY)(n) in gp120 of…
Most Relevant Clinical Trials
- Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)
- Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant
- A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or W…
- A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinan…
- HIV Vaccine in HIV-uninfected Adults
